GI/endoscopy company stock report – April 3, 2015

Here is a stock report on five publicly traded GI/endoscopy companies for March 27 to April 3.

Advertisement

•    AbbVie: $57.01 per share (down 0.16 percent)
•    Boston Scientific: $17.72 per share (up 0.4 percent)
•    FUJIFILM Holdings: $36.11 per share (up 2.32 percent)
•    Olympus: $36.66 per share (up 0 percent)
•    Valeant Pharmaceuticals: $198.45 per share (up 0.54 percent)

More articles on gastroenterology:
Dr. Timothy Miller: 3 ways to allay patients’ fear of colonoscopy
7 things for gastroenterologists to know for today – April 3, 2015
Fighting the decline: 3 gastroenterologists on standing up to reimbursement pressure

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Building a High-Performance Cardiac PET Program: What Health Systems Should Consider

Thursday, July 30
12:00 PM - 1:00 PM CDT

Presenters: Rupa Sanghani, MD, FACC, FASNC, Rush University Medical CenterBrendon Loiselle, CDL Nuclear Technologies

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.